Cellectar Biosciences (Nasdaq:CLRB), announced on 5/10/18 that the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development has granted Orphan Drug Designation to CLR 131, the... read more
Cellectar Biosciences (Nasdaq:CLRB), announced on 5/10/18 that the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development has granted Orphan Drug Designation to CLR 131, the... read more
Digital DNAtix Ltd., the genetics blockchain company, released its first open-source DNA Compression tool to GitHub today. It is almost impossible to transfer genetic data with current blockchain... read more
Eli Lilly and Company (NYSE: LLY) and ARMO BioSciences, Inc. (NASDAQ: ARMO) today announced a definitive agreement for Lilly to acquire ARMO for $50 per share, or approximately $1.6 billion, in an... read more
Roche announced on 5/10/18 that the Phase III IMblaze370 study evaluating the combination of Tecentriq (atezolizumab) and Cotellic (cobimetinib) did not meet its primary endpoint of overall... read more
Knopp Biosciences LLC announced on 5/10/18 the publication of a report in the journal Blood that a Phase 2 study of dexpramipexole in hypereosinophilic syndromes (HES) met its co-primary... read more